Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1287853

FEDRATINIB
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1

Basic Information

ChEMBL ID CHEMBL1287853
Name FEDRATINIB
Phase Approved
Structure Type MOL
InChI Key JOOXLOJCABQBSG-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Fedratinib Sar-302503 SAR302503 TG-101348 TG101348
300
Targets
492
Activities
4
Assay Types
12
PK Parameters
20
Publications
5
Known Names
8
Indications
2
Mechanisms

Molecular Properties

524.7
MW (Da)
4.82
ALogP
8
HBA
3
HBD
108.5
PSA (Ų)
0.35
QED
1
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2019
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning Natural Product
USAN Stem -tinib
USAN Year 2013

Extended Properties

Molecular Formula C27H36N6O3S
MW 524.69
Aromatic Rings 3
Heavy Atoms 37
NP-Likeness -1.71

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Tyrosine-protein kinase receptor FLT3 inhibitor INHIBITOR Receptor-type tyrosine-protein kinase FLT3
Tyrosine-protein kinase JAK2 inhibitor INHIBITOR Tyrosine-protein kinase JAK2

Indications

Neoplasms Primary Myelofibrosis Primary Myelofibrosis Leukemia, Neutrophilic, Chronic Myelodysplastic Syndromes Myeloproliferative Disorders Kidney Diseases Liver Diseases

ATC Classification

L01EJ02
fedratinib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS

Activity Summary

Kd 367 meas. best 8.96
IC50 121 meas. best 9.12
Ki 3 meas. best 6.98
EC50 1 meas. best 7.1

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Tyrosine-protein kinase JAK2
CHEMBL2971
IC50 9.12 7.636 0.8 42
Cyclin-G-associated kinase
CHEMBL4355
IC50 9.0 9.0 1.0 1
Tyrosine-protein kinase JAK2
CHEMBL2971
Kd 8.96 8.665 1.1 2
Cyclin-G-associated kinase
CHEMBL4355
Kd 8.96 8.15 1.1 2
Death-associated protein kinase 3
CHEMBL2468
Kd 8.92 8.92 1.2 1
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
Kd 8.31 7.6863 4.9 8
Janus Kinase (JAK)
CHEMBL2363062
IC50 8.22 8.22 6.0 1
Serine/threonine-protein kinase 16
CHEMBL3938
Kd 8.18 7.215 6.6 2
Receptor-type tyrosine-protein kinase FLT3
CHEMBL1974
IC50 7.98 6.7027 10.4 11
Tyrosine-protein kinase JAK1
CHEMBL2835
IC50 7.91 7.5629 12.3 7
Serine/threonine-protein kinase DCLK3
CHEMBL6123
Kd 7.89 7.89 13.0 1
Death-associated protein kinase 1
CHEMBL2558
Kd 7.8 7.8 16.0 1
Proto-oncogene tyrosine-protein kinase receptor Ret
CHEMBL2041
IC50 7.77 6.505 17.0 10
Tyrosine-protein kinase JAK1
CHEMBL2835
Kd 7.75 6.68 18.0 3
Mitogen-activated protein kinase kinase kinase 19
CHEMBL6191
Kd 7.72 7.72 19.0 1
Non-receptor tyrosine-protein kinase TYK2
CHEMBL3553
Kd 7.68 6.8967 21.0 3
SARS-CoV-2
CHEMBL4303835
IC50 7.62 7.62 24.0 2
Death-associated protein kinase 2
CHEMBL3123
Kd 7.54 7.54 29.0 1
AP2-associated protein kinase 1
CHEMBL3830
IC50 7.5 7.5 32.0 1
BMP-2-inducible protein kinase
CHEMBL4522
Kd 7.5 6.895 32.0 2
NUAK family SNF1-like kinase 1
CHEMBL5784
Kd 7.47 7.47 34.0 1
AP2-associated protein kinase 1
CHEMBL3830
Kd 7.46 6.955 35.0 2
Tyrosine-protein kinase Fyn
CHEMBL1841
Kd 7.42 7.42 38.0 1
Serine/threonine-protein kinase SIK1
CHEMBL6082
Kd 7.41 7.41 39.0 1
Tyrosine-protein kinase ABL1
CHEMBL1862
Kd 7.4 6.9127 40.0 15
Focal adhesion kinase 1
CHEMBL2695
Kd 7.38 7.07 42.0 2
Platelet-derived growth factor receptor beta
CHEMBL1913
Kd 7.35 7.35 45.0 1
Serine/threonine-protein kinase 17B
CHEMBL3980
Kd 7.35 7.35 45.0 1
Mast/stem cell growth factor receptor Kit
CHEMBL1936
Kd 7.34 6.6588 46.0 8
NUAK family SNF1-like kinase 2
CHEMBL5698
Kd 7.31 7.31 49.0 1
MV4-11
CHEMBL613835
IC50 7.24 7.24 57.0 1
Activated CDC42 kinase 1
CHEMBL4599
Kd 7.19 6.52 64.0 2
Mitogen-activated protein kinase 7
CHEMBL5332
Kd 7.18 6.53 66.0 2
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha
CHEMBL5969
Kd 7.18 7.18 66.0 1
MOLM-13
CHEMBL3706572
IC50 7.16 7.16 69.0 1
Proto-oncogene tyrosine-protein kinase receptor Ret
CHEMBL2041
Kd 7.15 6.748 71.0 5
Tyrosine-protein kinase Lck
CHEMBL258
Kd 7.14 7.14 72.0 1
Tyrosine-protein kinase JAK3
CHEMBL2148
Kd 7.13 7.1 74.0 2
Proto-oncogene tyrosine-protein kinase Src
CHEMBL267
Kd 7.12 7.12 75.0 1
NON-PROTEIN TARGET
CHEMBL3879801
EC50 7.1 7.1 79.0 1
Serine/threonine-protein kinase ULK2
CHEMBL5435
Kd 7.1 7.1 79.0 1
Tyrosine-protein kinase Fgr
CHEMBL4454
Kd 7.09 7.09 82.0 1
Serine/threonine-protein kinase TBK1
CHEMBL5408
Kd 7.04 6.345 92.0 2
Serine/threonine-protein kinase RIO3
CHEMBL5659
Kd 7.04 7.0267 91.0 3
Serine/threonine-protein kinase PLK4
CHEMBL3788
Kd 7.02 6.365 96.0 2
Serine/threonine-protein kinase SIK2
CHEMBL5699
Kd 7.01 6.505 98.0 2
Serine/threonine-protein kinase PknB
CHEMBL1908385
Kd 7.0 7.0 100.0 1
eIF-2-alpha kinase GCN2
CHEMBL5358
Kd 7.0 7.0 100.0 1
SRSF protein kinase 2
CHEMBL5668
Kd 7.0 7.0 100.0 1
Serine/threonine-protein kinase RIO1
CHEMBL5975
Kd 7.0 7.0 100.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 2825.0 ng.hr.mL-1 Mus musculus
AUC 14500.0 ng.hr.mL-1 Mus musculus
CL 976.1 mL.min-1.kg-1 Mus musculus
CL 3566.0 mL.min-1.kg-1 Mus musculus
Cmax 8437.36 nM Mus musculus
Cmax 18578.59 nM Mus musculus
Cmax 1850.62 nM Homo sapiens
F 102.0 % Mus musculus
T1/2 0.09333 hr Mus musculus
T1/2 5.45 hr Mus musculus
T1/2 2.88 hr Mus musculus
Tmax 0.08 hr Mus musculus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Tyrosine-protein kinase JAK2 IC50 = 0.75 nM 9.12 Inhibition of human JAK2 by radiometric assay 33570945
Cyclin-G-associated kinase IC50 = 1.0 nM 9.0 Inhibition of GAK (unknown origin) 33539089
Cyclin-G-associated kinase Kd = 1.1 nM 8.96 Binding constant for GAK kinase domain 22037378
Tyrosine-protein kinase JAK2 Kd = 1.1 nM 8.96 Binding constant for JAK2(JH1domain-catalytic) kinase domain 22037378
Death-associated protein kinase 3 Kd = 1.2 nM 8.92 Binding constant for DAPK3 kinase domain 22037378
Tyrosine-protein kinase JAK2 IC50 = 2.89 nM 8.54 Kinase Assay: JAK2 and JAK2 [V617F] Kinase Assay: In 5× Kinase Buffer A, JAK2 or... -
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) 28280261
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of human recombinant JAK2 by TR-FRET assay 21106455
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of GST tagged JAK2 (unknown origin) expressed in insect cells 19295546
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) 38852338
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) incubated for 30 mins in presence of ATP by ... 37683364
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 V617F mutant (unknown origin) 37793326
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) 37057760
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) 33356242
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of human JAK2 29870256
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) -
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 V617F mutant (unknown origin) 35749986
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK2 (unknown origin) 32120325
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of wild-type JAK2 (unknown origin) 35749986
Tyrosine-protein kinase JAK2 IC50 = 3.0 nM 8.52 Inhibition of JAK 2 (unknown origin) 33539089

Literature References

PubMed DOI Target Context # Activities
26254279 10.18632/oncotarget.4214 Tyrosine-protein kinase JAK2 19
37796543 10.1021/acs.jmedchem.3c01242 ADMET 18
22037378 10.1038/nbt.1990 Tyrosine-protein kinase ABL1 15
22037378 10.1038/nbt.1990 Epidermal growth factor receptor 12
22037378 10.1038/nbt.1990 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 10
26254279 10.18632/oncotarget.4214 Proto-oncogene tyrosine-protein kinase receptor Ret 9
26254279 10.18632/oncotarget.4214 Receptor-type tyrosine-protein kinase FLT3 9
22037378 10.1038/nbt.1990 Mast/stem cell growth factor receptor Kit 8
38843875 10.1021/acs.jmedchem.4c00197 Unchecked 7
22037378 10.1038/nbt.1990 Receptor-type tyrosine-protein kinase FLT3 7
32911308 10.1016/j.ejmech.2020.112667 Homo sapiens 5
29191878 10.1126/science.aan4368 Unchecked 4
37796543 10.1021/acs.jmedchem.3c01242 Tyrosine-protein kinase JAK1 4
33691794 10.1186/s13148-021-01037-1 A549 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
37796543 10.1021/acs.jmedchem.3c01242 Unchecked 4
37796543 10.1021/acs.jmedchem.3c01242 Bromodomain-containing protein 4 4
22037378 10.1038/nbt.1990 Proto-oncogene tyrosine-protein kinase receptor Ret 4
37796543 10.1021/acs.jmedchem.3c01242 MDA-MB-231 3
19295546 10.1038/leu.2009.50 Unchecked 3

Data from ChEMBL 36 via Core Engine